Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 9, 2011, Pages 961-965

  Rahkola, Pîivi ^a   VÎisÎnen Tommiska, Mervi ^a   Hiltunen Back, Eija ^a   Auvinen, Eeva ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chlamydia trachomatis; Infection; nitric oxide; papillomavirus; uterine cervix

Indexed keywords

DNA; NITRIC OXIDE; RNA;

ADULT; ARTICLE; ASSOCIATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL ARTICLE; CLINICAL STUDY; CONCURRENT INFECTION; FEMALE; HUMAN; OPEN STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX MUCUS;

ADOLESCENT; ADULT; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 80051906744     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01205.x     Document Type: Article

References (29)

1. Brunham RC, Rey-Ladino J,. Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005; 5: 149-61. (Pubitemid 40208904)
2. Debattista J, Timms P, Allan J, Allan J,. Immunopathogenesis of Chlamydia trachomatis infections in women. Fert Sterility. 2007; 79: 1273-1287.
3. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al,. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001; 285: 47-51. (Pubitemid 32042715)
4. Paavonen J, Lehtinen M,. Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer. Curr Opin Infect Dis. 1999; 12: 67-71. (Pubitemid 29095137)
5. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY,. Cervicovaginal coinfections with human papillomavirus and chlamydia trachomatis. Diagn Microbiol Infect Dis. 2002; 43: 277-81. (Pubitemid 34874769)
6. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al,. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 2002; 185: 324-31. (Pubitemid 34107245)
7. Denks K, Spaeth EL, Jõers K, Randoja R, Talpsep MU, Kurg R,. Coinfection of Chlamydia trachmatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia. Scand J Infect Dis. 2007; 39: 714-18. (Pubitemid 47180473)
8. Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, et al,. Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. 2009; 9: 16-23.
9. Keegan H, Rayan F, Malkin A, Griffin M, Lambkin H,. Chlamydia trachomatis detection in cervical PreservCyt specimens from an Irish urban female population. Cytopathology. 2009; 20: 111-16.
10. Tornblom SA, Maul H, Klimaviciute A, Garfield RE, Bystrom B, Malmstrom A, et al,. mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod Biol Endocrinol. 2005; 3: 33-41.
11. Vaisanen-Tommiska M, Nuutila M, Aittomaki K, Hiilesmaa V, Ylikorkala O,. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening. Am J Obstet Gynecol. 2003; 188: 779-85. (Pubitemid 36332451)
12. De Andrea M, Mondini M, Azzimonti B, Dell'oste V, Germano S, Gaudino G, et al,. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res. 2007; 124: 220-5. (Pubitemid 46216554)
13. Rahkola P, Mikkola TS, Nieminen P, Ylikorkala O, Vaisanen-Tommiska M,. Abnormal cervical cytology is associated with increased nitric oxide release in the uterine cervix. Acta Obstet Gynecol Scand. 2009; 5: 1-5.
14. Rahkola P, Mikkola TS, Ylikorkala O, Vaisanen-Tommiska M,. Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix. Gynecol Oncol. 2009; 114: 323-6.
15. Rahkola P, Vaisanen-Tommiska M, Tuomikoski P, Ylikorkala O, Mikkola TS,. Cervical nitric oxide release and persistence of high-risk human papillomavirus in women. Int J Cancer. 2011; 128: 2933-7.
16. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB,. Systematic review: Noninvasive testing for chlamydia trachomatis and neisseria gonorrhoeae. Ann Intern Med. 2005; 142: 914-25. (Pubitemid 40791807)
17. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI,. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun. 2001; 69: 5131-7. (Pubitemid 32674500)
18. Ramsey KH, Sigar IM, Rana SV, Gupta J, Holland SM, Byrne GI,. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect Immun. 2001; 69: 7374-9. (Pubitemid 33086561)
19. Roshick C, Wood H, Caldwell HD, McClarty G,. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun. 2006; 74: 225-38. (Pubitemid 43023077)
20. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H,. The role of IFN-γ in the outcome of chlamydial infection. Curr Opin Immunol. 2002; 14: 444-51. (Pubitemid 34671246)
21. Chen B, Stout R, Campbell WF,. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-γ-treated RAW264.7 cells. FEMS Immunol Med Microbiol. 1996; 14: 109-20. (Pubitemid 26185022)
22. Bogdan C,. Nitric oxide and the immune response. Nat Immunol. 2001; 2: 907-16. (Pubitemid 32976162)
23. Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL,. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect. 2009; 11: 435-42.
24. Hiraku Y, Tabata T, Ma N, Murata M, Ding X, Kawanishi S,. Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Sci. 2007; 98: 964-72. (Pubitemid 46865378)
25. Mazibrada J, Ritta M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, et al,. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol. 2008; 108: 112-20. (Pubitemid 350299432)
26. da Silva CS, Michelin MA, Etchebehere RM, Adad SJ, Murta EF,. Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia. Clinics (Sao Paulo). 2010; 65: 575-81.
27. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S,. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer. 1999; 85: 1139-44. (Pubitemid 29115594)
28. Machado Junior LC, Dalmaso AS, Carvalho HB,. Evidence for benefits from treating cervical ectopy: literature review. Sao Paulo Med J. 2008; 126: 132-9.
29. Wei L, Gravitt PE, Song H, Maldonado AM, Ozbun MA,. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res. 2009; 69: 4878-84.